Enzyme-independent functions of HDAC3 in the adult heart

IF 14.6 1区 医学 Q1 PHARMACOLOGY & PHARMACY
Sichong Qian , Chen Zhang , Wenbo Li , Shiyang Song , Guanqiao Lin , Zixiu Cheng , Wenjun Zhou , Huiqi Yin , Yueli Wang , Haiyang Li , Ying H. Shen , Zheng Sun
{"title":"Enzyme-independent functions of HDAC3 in the adult heart","authors":"Sichong Qian ,&nbsp;Chen Zhang ,&nbsp;Wenbo Li ,&nbsp;Shiyang Song ,&nbsp;Guanqiao Lin ,&nbsp;Zixiu Cheng ,&nbsp;Wenjun Zhou ,&nbsp;Huiqi Yin ,&nbsp;Yueli Wang ,&nbsp;Haiyang Li ,&nbsp;Ying H. Shen ,&nbsp;Zheng Sun","doi":"10.1016/j.apsb.2025.05.002","DOIUrl":null,"url":null,"abstract":"<div><div>The cardioprotective effects of histone deacetylase (HDAC) inhibitors (HDIs) are at odds with the deleterious effects of HDAC depletion. Here, we use HDAC3 as a prototype HDAC to address this contradiction. We show that adult-onset cardiac-specific depletion of HDAC3 in mice causes cardiac hypertrophy and contractile dysfunction on a high-fat diet (HFD), excluding developmental disruption as a major reason for the contradiction. Genetically abolishing HDAC3 enzymatic activity without affecting its protein level does not cause cardiac dysfunction on HFD. HDAC3 depletion causes robust downregulation of lipid oxidation/bioenergetic genes and upregulation of antioxidant/anti-apoptotic genes. In contrast, HDAC3 enzyme activity abolishment causes much milder changes in far fewer genes. The abnormal gene expression is cardiomyocyte-autonomous and can be rescued by an enzyme-dead HDAC3 mutant but not by an HDAC3 mutant (Δ33–70) that lacks interaction with the nuclear-envelope protein lamina-associated polypeptide 2<em>β</em> (LAP2<em>β</em>). Tethering LAP2<em>β</em> to the HDAC3 Δ33–70 mutant restored its ability to rescue gene expression. Finally, HDAC3 depletion, not loss of HDAC3 enzymatic activity, exacerbates cardiac contractile functions upon aortic constriction. These results suggest that the cardiac function of HDAC3 in adults is not attributable to its enzyme activity, which has implications for understanding the cardioprotective effects of HDIs.</div></div>","PeriodicalId":6906,"journal":{"name":"Acta Pharmaceutica Sinica. B","volume":"15 7","pages":"Pages 3561-3574"},"PeriodicalIF":14.6000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Pharmaceutica Sinica. B","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211383525003053","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

The cardioprotective effects of histone deacetylase (HDAC) inhibitors (HDIs) are at odds with the deleterious effects of HDAC depletion. Here, we use HDAC3 as a prototype HDAC to address this contradiction. We show that adult-onset cardiac-specific depletion of HDAC3 in mice causes cardiac hypertrophy and contractile dysfunction on a high-fat diet (HFD), excluding developmental disruption as a major reason for the contradiction. Genetically abolishing HDAC3 enzymatic activity without affecting its protein level does not cause cardiac dysfunction on HFD. HDAC3 depletion causes robust downregulation of lipid oxidation/bioenergetic genes and upregulation of antioxidant/anti-apoptotic genes. In contrast, HDAC3 enzyme activity abolishment causes much milder changes in far fewer genes. The abnormal gene expression is cardiomyocyte-autonomous and can be rescued by an enzyme-dead HDAC3 mutant but not by an HDAC3 mutant (Δ33–70) that lacks interaction with the nuclear-envelope protein lamina-associated polypeptide 2β (LAP2β). Tethering LAP2β to the HDAC3 Δ33–70 mutant restored its ability to rescue gene expression. Finally, HDAC3 depletion, not loss of HDAC3 enzymatic activity, exacerbates cardiac contractile functions upon aortic constriction. These results suggest that the cardiac function of HDAC3 in adults is not attributable to its enzyme activity, which has implications for understanding the cardioprotective effects of HDIs.

Abstract Image

成人心脏中HDAC3的酶非依赖性功能
组蛋白去乙酰化酶(HDAC)抑制剂(hdi)的心脏保护作用与HDAC耗尽的有害作用不一致。在这里,我们使用HDAC3作为HDAC的原型来解决这个矛盾。我们的研究表明,在高脂肪饮食(HFD)下,小鼠成年发病的心脏特异性HDAC3缺失会导致心脏肥厚和收缩功能障碍,排除了发育中断作为矛盾的主要原因。基因去除HDAC3酶活性而不影响其蛋白水平不会引起HFD患者的心功能障碍。HDAC3缺失导致脂质氧化/生物能量基因的下调和抗氧化/抗凋亡基因的上调。相比之下,HDAC3酶活性的消除在更少的基因中引起的变化要温和得多。异常基因表达是心肌细胞自主的,可以被酶死亡的HDAC3突变体拯救,但不能被缺乏与核膜蛋白层相关多肽2β (LAP2β)相互作用的HDAC3突变体(Δ33-70)拯救。将LAP2β系在HDAC3 Δ33-70突变体上恢复其挽救基因表达的能力。最后,HDAC3的缺失,而不是HDAC3酶活性的丧失,加重了主动脉收缩时的心脏收缩功能。这些结果表明,成人HDAC3的心脏功能不是归因于其酶活性,这对理解hdi的心脏保护作用具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
CiteScore
22.40
自引率
5.50%
发文量
1051
审稿时长
19 weeks
期刊介绍: The Journal of the Institute of Materia Medica, Chinese Academy of Medical Sciences, and the Chinese Pharmaceutical Association oversees the peer review process for Acta Pharmaceutica Sinica. B (APSB). Published monthly in English, APSB is dedicated to disseminating significant original research articles, rapid communications, and high-quality reviews that highlight recent advances across various pharmaceutical sciences domains. These encompass pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, and pharmacokinetics. A part of the Acta Pharmaceutica Sinica series, established in 1953 and indexed in prominent databases like Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, and Current Bibliography on Science and Technology, APSB is sponsored by the Institute of Materia Medica, Chinese Academy of Medical Sciences, and the Chinese Pharmaceutical Association. Its production and hosting are facilitated by Elsevier B.V. This collaborative effort ensures APSB's commitment to delivering valuable contributions to the pharmaceutical sciences community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信